SCHEMBL16229239

SCHEMBL16229239

COCCOC(=O)C1(OCCOC)CCC(c2nc3c(-c4ccc(C5=NC=CC5)nc4)cnn3c(N(COCC[Si](C)(C)C)COCC[Si](C)(C)C)c2Br)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15031514 0.92 — —
SCHEMBL15031453 0.90 DGAT1 (0.39) —
SCHEMBL16229241 0.90 — —
SCHEMBL15026300 0.89 DGAT1 (0.31) —
SCHEMBL15007530 0.89 DGAT1 (0.31) —
SCHEMBL15007529 0.89 DGAT1 (0.31) —
SCHEMBL16229240 0.88 — —
SCHEMBL16229238 0.88 MTOR (0.39) —
SCHEMBL16222860 0.88 DGAT1 (0.34) —
SCHEMBL15031516 0.85 DGAT1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883801-B2 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2014-11-11 — — US disclosed
Send feedback